US 7288624
Inhibitors of interleukin-1β converting enzyme
granted A61KA61K38/00
Quick answer
US patent 7288624 (Inhibitors of interleukin-1β converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00